Surgalign Holdings Inc. (SRGA)
$0.01
$0.00
(-8.33%)
As on 01-Sep-2023 09:30EDT
Market cap
$2 Mln
Revenue (TTM)
$78 Mln
P/E Ratio
--
P/B Ratio
1.8
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$-16 Mln
-
ROE
-15 %
-
ROCE
-- %
-
Industry P/E
44.46
-
EV/EBITDA
-0.6
-
Debt to Equity
-0.5
-
Book Value
$--
-
EPS
$--
-
Face value
--
-
Shares outstanding
9,183,450
10 Years Aggregate
CFO
$-129.18 Mln
EBITDA
$1.13 Mln
Net Profit
$-382.54 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Surgalign Holdings (SRGA)
| -99.4 | -54.2 | -98.6 | -99.7 | -94.5 | -84.8 | -59.8 |
|
BSE Sensex*
| -9.6 | -2.0 | 3.1 | -4.7 | 5.4 | 6.0 | 10.4 |
|
Company
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
2015
|
|---|---|---|---|---|---|---|---|
|
Surgalign Holdings (SRGA)
| -67.1 | -20.1 | -25.9 | -9.7 | 26.2 | -18.1 | -23.7 |
|
BSE Sensex
| 22.0 | 15.8 | 14.4 | 5.9 | 27.9 | 1.9 | -5.0 |
|
BSE Sensex
| 22.0 | 15.8 | 14.4 | 5.9 | 27.9 | 1.9 | -5.0 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Surgalign Holdings (SRGA)
|
0.0 | 1.7 | 78.1 | -50.5 | -112.4 | -- | -- | 1.8 |
| 60.0 | 8,018.1 | 616.9 | -75.1 | 1.7 | -9.3 | -- | 10.2 | |
| 14.6 | 9,638.1 | 6,561.1 | -578.0 | -4.5 | -10.3 | -- | 1.7 | |
| 365.1 | 9,761.6 | 2,589.3 | 222.4 | -6.0 | 3 | 44.5 | 1.3 | |
| 58.3 | 8,696.7 | 3,499.6 | -71.2 | 0.5 | -3.2 | -- | 3.8 | |
| 179.4 | 10,905.5 | 612.8 | -188.1 | -30.6 | -28.1 | -- | 16.4 | |
| 100.9 | 6,577.5 | 1,556.3 | 275.3 | 24.6 | 22.9 | 24.1 | 5.0 | |
| 324.4 | 12,752.7 | 1,504.9 | 160.6 | 13.6 | 10.9 | 79.4 | 8.4 | |
| 172.4 | 9,947.9 | 785.1 | 41.5 | 9.9 | 2 | 251.8 | 4.9 | |
| 28.9 | 12,153.4 | 6,164.0 | 625.0 | 13.0 | 11.8 | 19.9 | 2.4 |
Shareholding Pattern
View DetailsAbout Surgalign Holdings (SRGA)
Surgalign Holdings, Inc., a medical technology company, develops, manufactures, distributes, and markets spinal hardware implants and biomaterial products worldwide. It offers products for thoracolumbar procedures, including Streamline TL spinal... fixation system, a system for degenerative and complex spine procedures; and Streamline MIS spinal fixation system, a range of implants and instruments used via a percutaneous or mini-open approach; and interbody fusion devices, as well as products for cervical procedures, such as CervAlign ACP system, a comprehensive anterior cervical plate system; Fortilink-C IBF system, a cervical interbody fusion device that utilizes TETRAfuse 3D technology; and Streamline OCT system, a range of implants used in the occipito-cervico-thoracic posterior spine. The company also provides motion preservation systems comprising Coflex Interlaminar Stabilization device for the treatment of moderate to severe lumbar spinal stenosis in conjunction with decompression; HPS 2.0 Universal Fixation system, a pedicle screw system used for posterior stabilization of the thoracolumbar spine; and SImmetry SI Joint Fusion system, a minimally invasive surgical implant system to decrease opioid use, pain, and disability. In addition, it develops augmented reality and artificial intelligence digital surgery platform to enable digital spine surgery. The company markets its products through independent spine and biomaterial distributors to hospitals, ambulatory surgery centers, and healthcare providers, as well as through direct sales force. The company was incorporated in 1997 and is headquartered in Deerfield, Illinois. On June 19, 2023, Surgalign Holdings, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of Texas. Read more
-
Pres, CEO & Director
Mr. Terry M. Rich
-
Pres, CEO & Director
Mr. Terry M. Rich
-
Headquarters
Deerfield, IL
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Surgalign Holdings (SRGA)
What is the current share price of Surgalign Holdings Inc (SRGA) Today?
The share price of Surgalign Holdings Inc (SRGA) is $0.01 (NASDAQ) as of 01-Sep-2023 09:30 EDT. Surgalign Holdings Inc (SRGA) has given a return of -94.51% in the last 3 years.
What is the current PB & PE ratio of Surgalign Holdings Inc (SRGA)?
Since, TTM earnings of Surgalign Holdings Inc (SRGA) is negative, P/E ratio is not available.
The P/B ratio of Surgalign Holdings Inc (SRGA) is 1.79 times as on 01-Sep-2023, a 53 discount to its peers’ median range of 3.79 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2022 |
-- |
-- |
2021 |
-- |
-- |
2020 |
-- |
-- |
2019 |
-- |
-- |
2018 |
-- |
-- |
What is the 52 Week High and Low of Surgalign Holdings Inc (SRGA)?
The 52-week high and low of Surgalign Holdings Inc (SRGA) are Rs -- and Rs -- as of 02-Sep-2026.
What is the market cap of Surgalign Holdings Inc (SRGA)?
Surgalign Holdings Inc (SRGA) has a market capitalisation of $ 2 Mln as on 01-Sep-2023. As per SEBI classification, it is a company.
Should I invest in Surgalign Holdings Inc (SRGA)?
Before investing in Surgalign Holdings Inc (SRGA), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.